Jinfang Zhang

17PUBLICATIONS
75CO-AUTHORS
Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursChemical engineering design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jan 08, 2026
CDK10 suppresses nucleic acid sensors-mediated antitumor immunity.

Gaoshan Xu, Fusheng Guo, Chuan He

|Nov 12, 2025
Targeted destruction of VISTA boosts anti-tumor immunotherapy.

Li Chen, Xia Bu, Yishuang Sun

|Nov 12, 2025
Destruction of VISTA by TRIM25 ablation in T cells potentiates cancer immunotherapy.

Yishuang Sun, Zijian Zhang, Haiou Li

|Sep 05, 2025
ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion.

Jianhong Zhao, Baoxiang Chen, Yanrong Deng

|Jun 20, 2025
Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy.

Xiangling Xiao, Jie Shi, Chuan He

|May 16, 2025
USP2 inhibition unleashes CD47-restrained phagocytosis and enhances anti-tumor immunity.

Panpan Dai, Yishuang Sun, Zhengrong Huang

Pageof 3

Frequent Collaborators

12 joint publications

Wenyi Wei

6 joint publications

Jing Liu

6 joint publications

Gordon J Freeman

4 joint publications

Conghua Xie